About this trial
This prospective observational study aims to evaluate sarcopenia in intensive care patients with intracranial pathologies using ultrasound and to compare the predictive performance of different artificial intelligence models. Rectus femoris muscle thickness will be measured by ultrasound on ICU admission (Day 0) and Day 7. Prealbumin levels will be assessed on Days 0, 3, and 7, and the modified Nutrition Risk in Critically Ill (mNUTRIC) score will be calculated on the first day of ICU admission. Clinical, laboratory, and ultrasonographic data will be integrated into different artificial intelligence models to predict sarcopenia status on Day 7. The study aims to determine the effectiveness of artificial intelligence in the early identification of sarcopenia and to support future clinical decision-making in intensive care practice.
Eligibility criteria
Qualifiers
Age between 18 and 65 years
Admission to the intensive care unit due to intracranial pathology (intracerebral hemorrhage, epidural hemorrhage, subdural hemorrhage, subarachnoid hemorrhage, intracranial tumors, or ischemic stroke)
Informed consent obtained from the patient or legally authorized representative
Disqualifiers
Age <18 years or >65 years
Failure to achieve nutritional targets according to ESPEN guidelines
Palliative care or home care patients
Morbid obesity (BMI ≥40 kg/m²)
Trial design
Treatments tested in this trial
- Prospective Observational Assessment